Our Studies

Inner Space Research is currently enrolling patients in clinical trials for the following:

Jamie Robison 11/13/25 Jamie Robison 11/13/25

Schizophrenia | Outpatient | Neurocrine | NBI-1117568-SCZ3032

About the Study

This is a phase 3 open-label study evaluating the long-term safety and tolerability of the drug NBI-1117568 in the treatment of adults with schizophrenia.

This study is sponsored by Neurocrine Biosciences, Inc.

Our Studies

Inner Space Research is currently enrolling patients in clinical trials for the following:

Schizophrenia | Outpatient | Neurocrine | NBI-1117568-SCZ3032

About the Study

Clinical trials advance medicine for the benefit of communities everywhere.
Inner Space Research provides patients access to emerging therapies and generates the rigorous data regulatory agencies need to evaluate their safety and efficacy.

Inner Space Research LLC

Our Studies

Inner Space Research is currently enrolling patients in clinical trials for the following:

Schizophrenia | Outpatient | Neurocrine | NBI-1117568-SCZ3032

About the Study

Clinical trials advance medicine for the benefit of communities everywhere.Inner Space Research provides patients access to emerging therapies and generates the rigorous data regulatory agencies need to evaluate their safety and efficacy.

Inner Space Research LLC

Clinical trials advance medicine for the benefit of communities everywhere.
Inner Space Research provides patients access to emerging therapies and generates the rigorous data regulatory agencies need to evaluate their safety and efficacy.